Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-04-23
1994-10-25
Rizzo, Nicholas
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544284, 544287, A61K 3155, A61K 31505, C07D49804, C07D49808
Patent
active
053589513
ABSTRACT:
This disclosure describes novel 2,3,6, substituted quinazolinones of the formula: ##STR1## wherein R.sub.1, R.sup.6 and X are described in the specification which have activity as angiotensin II (AII) antagonistis.
REFERENCES:
patent: 5284853 (1994-02-01), Levin et al.
patent: 5288720 (1994-02-01), Albright
Levin Jeremy I.
Venkatesan Aranapakam M.
American Cyanamid Company
Grumbling Matthew V.
Rizzo Nicholas
Szatkowski Thomas S.
LandOfFree
Angiotensin II receptor blocking 2, 3, 6 substituted quinazolino does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Angiotensin II receptor blocking 2, 3, 6 substituted quinazolino, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Angiotensin II receptor blocking 2, 3, 6 substituted quinazolino will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-135610